KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Cash from Financing Activities (2016 - 2026)

Evolent Health has reported Cash from Financing Activities over the past 11 years, most recently at -$93.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 195.97% year-over-year to -$93.0 million; the TTM value through Dec 2025 reached -$35.9 million, down 6258.23%, while the annual FY2025 figure was -$35.9 million, 6258.23% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$93.0 million at Evolent Health, down from -$41.8 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $379.7 million in Q1 2023 and troughed at -$103.4 million in Q2 2024.
  • A 5-year average of $17.3 million and a median of -$9.0 million in 2024 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: soared 26901.72% in 2022 and later tumbled 677.15% in 2023.
  • Year by year, Cash from Financing Activities stood at $60.9 million in 2021, then plummeted by 117.82% to -$10.9 million in 2022, then tumbled by 677.15% to -$84.4 million in 2023, then soared by 214.93% to $96.9 million in 2024, then crashed by 195.97% to -$93.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for EVH at -$93.0 million in Q4 2025, -$41.8 million in Q3 2025, and -$8.9 million in Q2 2025.